2001-February Archives by Subject
Starting: Thu Feb 1 09:51:03 2001
Ending: Wed Feb 28 07:12:08 2001
Messages: 102
- [Pharm-policy] (no subject)
pkorthui@ucla.edu
- [Pharm-policy] 3/5/01: Protest in Philly and DC
Julie Davids
- [Pharm-policy] [Fwd: US Congress Letter to Bush to HIV/AIDS Pharmaceuticals]
Mike Palmedo
- [Pharm-policy] Aaron Zitner, Genes and Patent disputes
James Love
- [Pharm-policy] Activists Take Over GlaxoSmithKline Investor Relations Office
James Love
- [Pharm-policy] AFL-CIO resolution on FTAA; good provisions on IP (fwd)
Robert Weissman
- [Pharm-policy] Australian PBAC: Wooldridge accused as drug revolt grows
James Love
- [Pharm-policy] Australian Pharmaceutical Benefits Scheme: more trouble
James Love
- [Pharm-policy] Bangladesh Industries Minister asks for LDC extention on TRIPS
compliance
love@cptech.org
- [Pharm-policy] BBC: Thais battle firms over AIDS drugs
love@cptech.org
- [Pharm-policy] BioChem evergreening of 3TC patent
love@cptech.org
- [Pharm-policy] BMS, Pfizer ask CIPLA for time to respond to voluntary license request
James Love
- [Pharm-policy] Boehringer-Ingelheim firm on SA patent lawsuit
love@cptech.org
- [Pharm-policy] Brazil asks WTO to examine US local working requirements in federally
funded inventions
love@cptech.org
- [Pharm-policy] Brazil Compulsory License Law
James Love
- [Pharm-policy] Brazil/WTO case: USTR Response to Gregg Gonsalves
James Love
- [Pharm-policy] Britain dangles tax breaks for drugs groups helping developing world
James Love
- [Pharm-policy] Brundtland on CIPLA to staff
James Love
- [Pharm-policy] CBC Transcript "The Situation of People Infected with HIV in Sub-Saharan
Africa"
James Love
- [Pharm-policy] Chris Adams in WSJ on commericalization of chris.adams@wsj.comfederally
funded R&D
love@cptech.org
- [Pharm-policy] CIPLA offers $350 yr 3 drug cocktail to MSF
James Love
- [Pharm-policy] Cipla on its offer
Mike Palmedo
- [Pharm-policy] CIPLA to offer Indinavir, Efavirenz, drops Indian prices
James Love
- [Pharm-policy] CPT comment on US/Brazil dispute
love@cptech.org
- [Pharm-policy] CPT reaction to MSF CIPLA joint statement
James Love
- [Pharm-policy] CPT response to Linda Horton
James Love
- [Pharm-policy] Crisis in the Australian PBS (cont)
James Love
- [Pharm-policy] David Henry, an unlikely villain?
James Love
- [Pharm-policy] Declan Walsh on Kenyan AIDS orphanage civil disobedience
love@cptech.org
- [Pharm-policy] Dorothy Guellec: The real scoop on Patient Assistance Programs
James Love
- [Pharm-policy] Drug Industry Jolted by Cipla AIDS-Drug Offer
James Love
- [Pharm-policy] FDA Orange Book patents web site
James Love
- [Pharm-policy] formatting fixed: Brundtland on CIPLA to staff
James Love
- [Pharm-policy] FYI-GMHC to USTR on Brazil
Gonsalves, Gregg
- [Pharm-policy] Glaxo clashes with Tshabalala-Msimang on AIDS drug prices
love@cptech.org
- [Pharm-policy] Glaxo response on CIPLA/Ghana dispute
James Love
- [Pharm-policy] Glaxo's claims of patent protection on antiretrovirals in Ghana
Toby Kasper
- [Pharm-policy] Hatch/Waxman and 30 month period after patent infringment issue is
raised
James Love
- [Pharm-policy] Heimboldsheart.com
James Love
- [Pharm-policy] Hindu on CIPLA offer
James Love
- [Pharm-policy] India drug export sales surge
love@cptech.org
- [Pharm-policy] India to block import of cheap drugs from China and Taiwan
love@cptech.org
- [Pharm-policy] Joint MSF/CIPLA statement
James Love
- [Pharm-policy] Ken Harvey's Feb 1 comments on Australian PBAC problems
James Love
- [Pharm-policy] Kenya debate over CIPLA offer
love@cptech.org
- [Pharm-policy] Kenya: Anger over drug prices
love@cptech.org
- [Pharm-policy] LA Times on Bush/USTR AIDS policy
love@cptech.org
- [Pharm-policy] Lancet editorial on South Africa Patent dispute
James Love
- [Pharm-policy] Linda Horton on TACD and generic quality
James Love
- [Pharm-policy] Linkage of Patents and drug registration
James Love
- [Pharm-policy] Malaysia: Allow ASEAN to make anti-AIDS drugs
love@cptech.org
- [Pharm-policy] MNCs allege Cipla's African `aid' violates patent
love@cptech.org
- [Pharm-policy] More on Australian PBS
Mike Palmedo
- [Pharm-policy] Morton Mintz earlier US debate on compulsory licensing, from Kefauver's
hearings
James Love
- [Pharm-policy] MSF Open Letter to Pascal Lamy re South Africa
James Love
- [Pharm-policy] NYT: Bush Keeps Clinton Policy on Poor Lands' Need for AIDS Drugs
Paul Davis
- [Pharm-policy] Nytimes editorial: bush admin & Fighting AIDS in Africa
James Love
- [Pharm-policy] Oxfam attacks Glaxo over price of Aids drugs
love@cptech.org
- [Pharm-policy] Oxfam Drug campaign in the news
Mike Palmedo
- [Pharm-policy] Philly Inquirer: Piot says Patent Deal Doesn't Work for the South
Paul Davis
- [Pharm-policy] PhRMA on price cuts
James Love
- [Pharm-policy] R&D on cheaper HIV testing technologies
James Love
- [Pharm-policy] Rachel Zimmerman: WSJ on Pediatric patent extention
James Love
- [Pharm-policy] Ranbaxy to foray into anti-AIDS drugs market
love@cptech.org
- [Pharm-policy] Raw Materials prices for HIV drugs
James Love
- [Pharm-policy] RE: [Ip-health] Brazil Compulsory License Law
Toby Kasper
- [Pharm-policy] RE: [Ip-health] Dorothy Guellec: The real scoop on Patient Assistance
Programs
James Love
- [Pharm-policy] RE: [Ip-health] HIV testing patents
Gonsalves, Gregg
- [Pharm-policy] RE: [Ip-health] HIV testing patents
Gonsalves, Gregg
- [Pharm-policy] RE: [Ip-health] HIV testing patents
Gonsalves, Gregg
- [Pharm-policy] Re: [Ip-health] HIV testing patents
Ezio Santos-Filho
- [Pharm-policy] RE: [Ip-health] HIV testing patents
richardl@bu.edu
- [Pharm-policy] Re: Guardian article today.
Alan Story
- [Pharm-policy] RE: R&D on cheaper HIV testing technologies
richardl@bu.edu
- [Pharm-policy] RE: R&D on cheaper HIV testing technologies
Gonsalves, Gregg
- [Pharm-policy] Re:CIPLA offers $350 yr 3 drug cocktail to MSF
Kate Krauss
- [Pharm-policy] Richard Laing on generic quality
James Love
- [Pharm-policy] Richard Stern on what needs to be done next
James Love
- [Pharm-policy] Simon Barber take on Bush announcement
James Love
- [Pharm-policy] TAC Statement on CIPLA -- Minister Erwin Issue Compulsory Licences Now!
James Love
- [Pharm-policy] TAC Statement on Democratic Alliance -- 15 February 2001
James Love
- [Pharm-policy] TAC statement on US/Brazil complaint
James Love
- [Pharm-policy] Teva's 1999 testimony on abuse of FDA 30 month rule
James Love
- [Pharm-policy] The Hindu on Ranbaxy entry in HIV market
love@cptech.org
- [Pharm-policy] Time Magazine Story
Mike Palmedo
- [Pharm-policy] Tshabalala-Msimang on CIPLA offer
love@cptech.org
- [Pharm-policy] Uganda: Glaxo's Nov 20 letter CIPLA reg Duovir
love@cptech.org
- [Pharm-policy] UNAIDS call for compulsory licensing and price cuts
love@cptech.org
- [Pharm-policy] UPI story on Brazil
Mike Palmedo
- [Pharm-policy] US lawmaker to seek compulsory license for Napster!
James Love
- [Pharm-policy] USTR statement on HIV/AIDS and trade policy
James Love
- [Pharm-policy] USTR to continue "flexiable" trade policy on access to medicines
James Love
- [Pharm-policy] Washington Post Editorial
MFJorge@aol.com
- [Pharm-policy] Washington Post editorial: Patent Wrongs
James Love
- [Pharm-policy] Washington Post: U.S., Brazil Clash Over AIDS Drugs
James Love
- [Pharm-policy] Washington Post: S. Africa Relents on Maternal HIV Care
Mike Palmedo
- [Pharm-policy] WHO statement of CIPLA offer
love@cptech.org
- [Pharm-policy] WHO Statement on CIPLA offer
James Love
- [Pharm-policy] WP- Kenyan Orphanage Takes Initiative on AIDS Drugs
Mike Palmedo
- [Pharm-policy] WSJ on Brazil WTO case
love@cptech.org
- [Pharm-policy] WSJ on CIPLA offer
love@cptech.org
- [Pharm-policy] WSJ on CIPLA's voluntary license request
love@cptech.org
Last message date:
Wed Feb 28 07:12:08 2001
Archived on: Wed Feb 28 07:12:09 2001
This archive was generated by
Pipermail 0.05 (Mailman edition).